| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 01/21/2004 | CN1469755A Vaccines containing ribavirin and methods of use thereof |
| 01/21/2004 | CN1468956A Recombinant virus of antibody for high-efficiency expression to treat tumor and its use |
| 01/21/2004 | CN1468955A New type of coronavirus |
| 01/21/2004 | CN1135262C Process for high efficiently multiplying hepatitis C virus and carrier used for the same method |
| 01/20/2004 | US6680060 A live hepatitis a virus adapted to growth in mrc-5 cells (human fibroblast-like cell line) |
| 01/20/2004 | US6680059 Vaccines containing ribavirin and methods of use thereof |
| 01/15/2004 | WO2004005524A1 Hepatitis c virus particle formation |
| 01/15/2004 | WO2004005511A1 Tumor-lysing virus growing selectively in tumor cells |
| 01/15/2004 | WO2004005498A1 Chimeric gb virus b (gbv-b) |
| 01/15/2004 | WO2004005493A1 Animal protein free media for cultivation of cells |
| 01/15/2004 | WO2004005322A2 Humanized renilla reniformis green fluorescent protein as a scaffold |
| 01/15/2004 | WO2004004495A1 Virulent phages to control listeria monocytogenes in foodstuffs and in food processing plants |
| 01/15/2004 | WO2003078592A3 Method for the purification, production and formulation of oncolytic adenoviruses |
| 01/15/2004 | WO2003063783A3 Multiple virus replicon culture systems |
| 01/15/2004 | WO2003004620A3 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 01/15/2004 | WO2002066629A9 Recombinant vector containing infectious human cytomegalovirus genome with preserved wild-type characteristics of clinical isolates |
| 01/15/2004 | US20040009603 Antiviral vectors |
| 01/15/2004 | US20040009588 Comprises targeted adenoviral expression vector coding antitumor agent; gene therapy; gene expression inhibition |
| 01/15/2004 | US20040009193 Lipid bilayer membrane derived from a eukaryotic microorganism as an outer membrane |
| 01/15/2004 | US20040009190 Recombinant attenuation of porcine reproductive and respiratory syndrome (PRRSV) |
| 01/15/2004 | CA2492074A1 Humanized renilla reniformis green fluorescent protein as a scaffold |
| 01/15/2004 | CA2491992A1 Animal protein free media for cultivation of cells |
| 01/15/2004 | CA2491907A1 Oncolytic virus replicating selectively in tumor cells |
| 01/14/2004 | EP1380651A2 Recombinant fowlpox virus with intact FPV-tk-gene |
| 01/14/2004 | EP1379671A2 Methods to culture circovirus |
| 01/14/2004 | EP1379660A2 Self-replicating rna molecule from hepatitis c virus |
| 01/14/2004 | EP1379656A2 G-protein coupled receptor molecules and uses thereof |
| 01/14/2004 | EP1379535A2 Expression vectors able to elicit improved immune response and methods of using same |
| 01/14/2004 | EP1379282A2 Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders |
| 01/14/2004 | EP1379281A2 A helper dependent adenoviral vector system and methods for using the same |
| 01/14/2004 | EP1379134A1 Recombinant adeno-assocaited virus-mediated gene transfer via retroductal infusion of virions |
| 01/14/2004 | CN1468301A Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes |
| 01/14/2004 | CN1468089A Microparticles for delivery of the heterologous nucleic acids |
| 01/14/2004 | CN1467293A Infectious bursal disease virus (IBDV) polyprotein gene (VP2/VP4/VP3), eukaryon expressing plasmid, DNA vaccine |
| 01/14/2004 | CN1134666C Method and reagent used for detecting virus of hepatitis C |
| 01/13/2004 | US6677156 Non-adenoviral gene product-based complementing cells for adenoviral vectors |
| 01/13/2004 | US6676936 Chimeric and/or growth-restricted flaviviruses |
| 01/13/2004 | CA2112811C Continuous cell line and vaccine against avian coccidia |
| 01/08/2004 | WO2004003184A1 A method for obtaining purified bacteriophage preparation s |
| 01/08/2004 | WO2004003153A2 Live replicating spumavirus vector |
| 01/08/2004 | WO2004003143A2 Viruses and virus-like particles for multiple antigen and target display |
| 01/08/2004 | WO2003020876A3 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof |
| 01/08/2004 | WO2003008533A3 Method for virus propagation |
| 01/08/2004 | US20040005711 Alphaviral vector system comprising papilloma viral orgin of replication and antitumor agent for prevention and treatment urogenital cancer; gene therapy |
| 01/08/2004 | US20040005710 Method for producing recombinant viruses using site-specific recombination |
| 01/08/2004 | US20040005693 Propagating and extracting reovirus from human embryonic kidney cells; ion exchange chromatography |
| 01/08/2004 | US20040005545 Plasmid comprising heterologous viral gene sequences for diagnosis, prevention and treatment of respiratory system disorders; vaccine development; viricides |
| 01/08/2004 | US20040005544 Comprise RNA viruses for diagnosis, prevention and treatment of repiratory system disorders; vaccine development; viricides; antisense therapy |
| 01/08/2004 | US20040005542 Respiratory syncytial virus vaccines expressing protective antigens from promotor- proximal genes |
| 01/08/2004 | US20040005539 Comprises expression vector coding antibody domains and heterologous proteins for use as model in design of improved binding domains; enzyme inhibitors |
| 01/08/2004 | US20040005338 Virus like particles (VLPs) can be loaded and packaged, respectively, with DNA oligonucleotides rich in non-methylated C and G (CpGs). If such CpG-VLPs are mixed with antigens, the immunogenicity of these antigens are |
| 01/08/2004 | CA2492131A1 Live replicating spumavirus vector |
| 01/08/2004 | CA2490866A1 Viruses and virus-like particles for multiple antigen and target display |
| 01/07/2004 | EP1378516A1 Mixture of recombinant vaccinia vectors as polyenv vaccines for HIV |
| 01/07/2004 | EP1377672A2 Vector constructs |
| 01/07/2004 | EP1377671A2 Oncolytic adenoviral vectors |
| 01/07/2004 | EP1377668A2 Artificial chromosomes comprising ehv sequences |
| 01/07/2004 | EP1377157A2 Novel pesticidal toxins |
| 01/07/2004 | EP1230354B1 Permanent amniocyte cell line, the production thereof and its use for producing gene transfer vectors |
| 01/07/2004 | CN1133745C Method for immortalizing cells and immortalized cell |
| 01/06/2004 | US6673601 Plasmid; expression vector encodes glycoprotein |
| 01/06/2004 | US6673591 Increasing permissiveness of cell to viral replication by decreasing expression of interferon by making cell deficient in factor that regulates interferon expression in vivo |
| 01/06/2004 | US6673572 Transfection of transcription or gene expression vectors in cells, then heating to improve recovery of myxoviruses, parainfluenza or respiratory syncytial virus; genetic engineering |
| 01/06/2004 | US6673349 Crosslinking; forming vaccines |
| 01/02/2004 | EP1375670A1 Recombinant measles viruses expressing epitopes of antigens of RNA viruses and use of the recombinant viruses for the preparation of vaccine compositions |
| 01/02/2004 | EP1375648A1 Methods for detecting and adjusting replication of hepatitis b virus and for preparing mutated virus strains with altered replication efficiency |
| 01/02/2004 | EP1375512A1 Infectious cDNA of an approved vaccine strain of measles virus. Use for immunogenic compositions |
| 01/02/2004 | EP1374910A1 Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection |
| 01/02/2004 | EP1373544A1 A method for transfer of dna segments |
| 01/02/2004 | EP1373537A2 Viral vectors |
| 01/02/2004 | EP1373536A2 Lentiviral packaging constructs |
| 01/02/2004 | EP1373524A2 Cytomegalovirus intron a fragments |
| 01/02/2004 | EP1373478A1 Attenuated live vaccine |
| 01/02/2004 | EP1373477A2 A novel virus (cryptovirus) within the rubulavirus genus and uses therefor |
| 01/02/2004 | EP1372712A2 Equine herpesvirus vaccine |
| 01/02/2004 | EP1372710A2 Mva expressing modified hiv envelope, gag, and pol genes |
| 01/02/2004 | EP0831921B1 Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection |
| 01/01/2004 | US20040002159 Methods for the production of chimeric adeno-associated virus (AAV) vectors, compositions of chimeric AAV vectors, and methods of use thereof |
| 01/01/2004 | US20040002061 Methods of using the signal to transmit and maintain influenza viral and foreign nucleic acid in virus and cells |
| 01/01/2004 | US20040002060 For efficient targeting of adenoviral vectors; can be combined with other modifications, such as fiber knob and/or penton modifications, to produce fully ablated (detargeted) adenoviral vectors |
| 01/01/2004 | US20040002058 Chimeric capsid proteins and uses thereof |
| 01/01/2004 | US20040002057 Cloning vectors and methods for producing a library of DNA molecules capable of expressing a fusion polypeptide on the surface of a filamentous phage particle |
| 01/01/2004 | US20040001863 Immortal cell line derived from grouper Epinephelus coioides and its applications therein |
| 01/01/2004 | US20040001850 Dna sequences; genetic engineering |
| 01/01/2004 | US20040001805 Prevention infections; gene therapy; insertion of genome; genetic engineered vaccine |
| 12/31/2003 | WO2004001051A2 Recombinant measles viruses expressing epitopes pf antigens of rna viruses and use of the recombinant viruses for the preparation of vaccine compositions |
| 12/31/2003 | WO2004001032A2 Stable adenoviral vectors and methods for propagation thereof |
| 12/31/2003 | WO2004001026A1 Method of preparing recombinant mononegaviruses and the applications thereof |
| 12/31/2003 | WO2004000876A1 INFECTIOUS cDNA OF AN APPROVED VACCINE STRAIN OF MEASLES VIRUS, USE FOR IMMUNOGENIC COMPOSITIONS |
| 12/31/2003 | WO2004000872A2 Improved alphavirus vectors having attenuated virion structural proteins |
| 12/31/2003 | WO2004000220A2 Methods for purifying viral particles for gene therapy |
| 12/31/2003 | WO2004000207A2 Toxin-phage bacteriocide antibiotic and uses thereof |
| 12/31/2003 | WO2003089015A3 Rapid sterilization and vaccine preparation |
| 12/31/2003 | WO2003073918A3 Prevention of recurrence and metastasis of cancer |
| 12/31/2003 | WO2003035889A3 Compositions and methods for bacteria detection |
| 12/31/2003 | WO2002088347A3 Aav helper plasmids for helper virus-free packaging and pseudo typification of aav vectors |
| 12/31/2003 | CN1132936C Purificaltion process of sea fish lymphocysis virus |
| 12/31/2003 | CN1132935C Metoxenous armyworm granule virus with synergistic action to insect virus and its preparing process and application |
| 12/31/2003 | CA2829581A1 Recombinant measles viruses expressing epitopes of antigens of rna viruses - use for the preparation of vaccine compositions |
| 12/31/2003 | CA2493834A1 Recombinant measles viruses expressing epitopes of antigens of rna viruses - use for the preparation of vaccine compositions |